In SSc skin, it is therefore reasonable to suppose that a concomitant decline in the lymphatic endothelial expression of VEGFR-3/Flt-4 and NRP-2 may profoundly hamper the lymphangiogenic process, contributing to a relentless loss of the lymphatic capillary network. The gene discussed is FLT4; the disease is systemic sclerosis.